AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

AstraZeneca

ClinicalTrials.gov Identifier:

NCT01597388

First received: March 28, 2012

Last updated: July 21, 2016

Last verified: July 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2017
Estimated Primary Completion Date:	August 2016 (Final data collection date for primary outcome measure)